Medtronic's High Dividend Yield Gets Little Attention on Wall Street -- Should You Buy the Stock Anyway?
The medical device giant grew its top line by a double-digit percentage in the first quarter of its fiscal 2027.
Overview
Shares of Medtronic (NYSE: MDT) have been struggling for years. They're down more than 7% so far in 2026 and off by more than 32% over the past five years.
The Irish medical device company posted its fiscal 2027 first-quarter report on Sept. 1, and despite its strong results, the market's reaction was tepid. Shares have fallen by 3% since the report was released.
There's an upside to this, though, for anyone considering investing in the medical equipment stock. While the underlying business appears to be in the midst of a comeback, due to its declining share price, its dividend yield has risen to 3.2%.
Details
Source
Originally published at www.fool.com.